MET inhibition overcomes radiation resistance of glioblastoma stem-like cells

作者：De Bacco Francesca; D' Ambrosio Antonio; Casanova Elena; Orzan Francesca; Neggia Roberta; Albano Raffaella; Verginelli Federica; Cominelli Manuela; Poliani Pietro L; Luraghi Paolo; Reato Gigliola; Pellegatta Serena; Finocchiaro Gaetano; Perera Timothy; Garibaldi Elisabetta; Gabriele Pietro; Comoglio Paolo M; Boccaccio Carla

来源：EMBO Molecular Medicine, 2016, 8(5): 550-568.

DOI：10.15252/emmm.201505890

• glioblastoma
• glioblastoma stem-like cells
• MET oncogene
• radiosensitization
• radiotherapy

Glioblastoma (GBM) contains stem-like cells (GSCs) known to be resistant to ionizing radiation and thus responsible for therapeutic failure and rapidly lethal tumor recurrence. It is known that GSC radioresistance relies on efficient activation of the DNA damage response, but the mechanisms linking this response with the stem status are still unclear. Here, we show that the MET receptor kinase, a functional marker of GSCs, is specifically expressed in a subset of radioresistant GSCs and overexpressed in human GBM recurring after radiotherapy. We elucidate that MET promotes GSC radioresistance through a novel mechanism, relying on AKT activity and leading to (i) sustained activation ofAurora kinase A, ATM kinase, and the downstream effectors of DNA repair, and (ii) phosphorylation and cytoplasmic retention of p21, which is associated with anti-apoptotic functions. We show that MET pharmacological inhibition causes DNA damage accumulation in irradiated GSCs and their depletion invitro and in GBMs generated by GSC xenotransplantation. Preclinical evidence is thus provided that MET inhibitors can radiosensitize tumors and convert GSC-positive selection, induced by radiotherapy, into GSC eradication.

• 出版日期2016-5